CD38モノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global CD38 Monoclonal Antibodies Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-00525 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、CD38モノクローナル抗体の世界市場を広く調査・分析し、今後の市場展望をまとめております。CD38モノクローナル抗体の種類別市場規模（ダラツマブ、イサツキシマブ）、用途別市場規模（薬局、研究室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Johnson & Johnson、Carbosynth、Sanofi、Janssen Biotech、BOC Sciences、Creative Biolabs ・地域別グローバル市場分析 2015年-2020年 ・CD38モノクローナル抗体の北米市場（アメリカ、カナダ、メキシコ） ・CD38モノクローナル抗体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・CD38モノクローナル抗体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・CD38モノクローナル抗体の南米市場（ブラジル、アルゼンチン） ・CD38モノクローナル抗体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ダラツマブ、イサツキシマブ ・用途別分析：薬局、研究室 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The CD38 Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global CD38 Monoclonal Antibodies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
CD38 Monoclonal Antibodies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, CD38 Monoclonal Antibodies market has been segmented into:
Daratumumab
Isatuximab

By Application, CD38 Monoclonal Antibodies has been segmented into:
Pharmacy
Laboratory Use

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global CD38 Monoclonal Antibodies market presented in the report. This section sheds light on the sales growth of different regional and country-level CD38 Monoclonal Antibodies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CD38 Monoclonal Antibodies market.

The report offers in-depth assessment of the growth and other aspects of the CD38 Monoclonal Antibodies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and CD38 Monoclonal Antibodies Market Share Analysis
CD38 Monoclonal Antibodies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CD38 Monoclonal Antibodies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CD38 Monoclonal Antibodies sales, revenue and market share for each player covered in this report.

The major players covered in CD38 Monoclonal Antibodies are:
Johnson & Johnson
Carbosynth
Sanofi
Janssen Biotech
BOC Sciences
Creative Biolabs
Among other players domestic and global, CD38 Monoclonal Antibodies market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 CD38 Monoclonal Antibodies Market Overview
1.1 Product Overview and Scope of CD38 Monoclonal Antibodies
1.2 Classification of CD38 Monoclonal Antibodies by Type
1.2.1 Global CD38 Monoclonal Antibodies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global CD38 Monoclonal Antibodies Revenue Market Share by Type in 2019
1.2.3 Daratumumab
1.2.4 Isatuximab
1.3 Global CD38 Monoclonal Antibodies Market by Application
1.3.1 Overview: Global CD38 Monoclonal Antibodies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmacy
1.3.3 Laboratory Use
1.4 Global CD38 Monoclonal Antibodies Market by Regions
1.4.1 Global CD38 Monoclonal Antibodies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of CD38 Monoclonal Antibodies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CD38 Monoclonal Antibodies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson SWOT Analysis
2.1.4 Johnson & Johnson Product and Services
2.1.5 Johnson & Johnson CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.2 Carbosynth
2.2.1 Carbosynth Details
2.2.2 Carbosynth Major Business
2.2.3 Carbosynth SWOT Analysis
2.2.4 Carbosynth Product and Services
2.2.5 Carbosynth CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Janssen Biotech
2.4.1 Janssen Biotech Details
2.4.2 Janssen Biotech Major Business
2.4.3 Janssen Biotech SWOT Analysis
2.4.4 Janssen Biotech Product and Services
2.4.5 Janssen Biotech CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.5 BOC Sciences
2.5.1 BOC Sciences Details
2.5.2 BOC Sciences Major Business
2.5.3 BOC Sciences SWOT Analysis
2.5.4 BOC Sciences Product and Services
2.5.5 BOC Sciences CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Creative Biolabs
2.6.1 Creative Biolabs Details
2.6.2 Creative Biolabs Major Business
2.6.3 Creative Biolabs Product and Services
2.6.4 Creative Biolabs CD38 Monoclonal Antibodies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global CD38 Monoclonal Antibodies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 CD38 Monoclonal Antibodies Players Market Share
3.2.2 Top 10 CD38 Monoclonal Antibodies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global CD38 Monoclonal Antibodies Revenue and Market Share by Regions
4.2 North America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.3 Europe CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.5 South America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5 North America CD38 Monoclonal Antibodies Revenue by Countries
5.1 North America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
5.2 USA CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5.3 Canada CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
5.4 Mexico CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6 Europe CD38 Monoclonal Antibodies Revenue by Countries
6.1 Europe CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
6.2 Germany CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.3 UK CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.4 France CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.5 Russia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
6.6 Italy CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific CD38 Monoclonal Antibodies Revenue by Countries
7.1 Asia-Pacific CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
7.2 China CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.3 Japan CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.4 Korea CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.5 India CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
8 South America CD38 Monoclonal Antibodies Revenue by Countries
8.1 South America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
8.2 Brazil CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
8.3 Argentina CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue CD38 Monoclonal Antibodies by Countries
9.1 Middle East & Africa CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
9.2 Saudi Arabia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.3 UAE CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.4 Egypt CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
9.5 South Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global CD38 Monoclonal Antibodies Revenue and Market Share by Type (2015-2020)
10.2 Global CD38 Monoclonal Antibodies Market Forecast by Type (2019-2024)
10.3 Daratumumab Revenue Growth Rate (2015-2025)
10.4 Isatuximab Revenue Growth Rate (2015-2025)
11 Global CD38 Monoclonal Antibodies Market Segment by Application
11.1 Global CD38 Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
11.2 CD38 Monoclonal Antibodies Market Forecast by Application (2019-2024)
11.3 Pharmacy Revenue Growth (2015-2020)
11.4 Laboratory Use Revenue Growth (2015-2020)
12 Global CD38 Monoclonal Antibodies Market Size Forecast (2021-2025)
12.1 Global CD38 Monoclonal Antibodies Market Size Forecast (2021-2025)
12.2 Global CD38 Monoclonal Antibodies Market Forecast by Regions (2021-2025)
12.3 North America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.4 Europe CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.6 South America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global CD38 Monoclonal Antibodies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of CD38 Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global CD38 Monoclonal Antibodies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market CD38 Monoclonal Antibodies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global CD38 Monoclonal Antibodies Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Johnson & Johnson Corporate Information, Location and Competitors
Table 7. Johnson & Johnson CD38 Monoclonal Antibodies Major Business
Table 8. Johnson & Johnson CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 9. Johnson & Johnson SWOT Analysis
Table 10. Johnson & Johnson CD38 Monoclonal Antibodies Product and Solutions
Table 11. Johnson & Johnson CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Carbosynth Corporate Information, Location and Competitors
Table 13. Carbosynth CD38 Monoclonal Antibodies Major Business
Table 14. Carbosynth CD38 Monoclonal Antibodies Total Revenue (USD Million) (2018-2019)
Table 15. Carbosynth SWOT Analysis
Table 16. Carbosynth CD38 Monoclonal Antibodies Product and Solutions
Table 17. Carbosynth CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Sanofi Corporate Information, Location and Competitors
Table 19. Sanofi CD38 Monoclonal Antibodies Major Business
Table 20. Sanofi CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 21. Sanofi SWOT Analysis
Table 22. Sanofi CD38 Monoclonal Antibodies Product and Solutions
Table 23. Sanofi CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Janssen Biotech Corporate Information, Location and Competitors
Table 25. Janssen Biotech CD38 Monoclonal Antibodies Major Business
Table 26. Janssen Biotech CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 27. Janssen Biotech SWOT Analysis
Table 28. Janssen Biotech CD38 Monoclonal Antibodies Product and Solutions
Table 29. Janssen Biotech CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. BOC Sciences Corporate Information, Location and Competitors
Table 31. BOC Sciences CD38 Monoclonal Antibodies Major Business
Table 32. BOC Sciences CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 33. BOC Sciences SWOT Analysis
Table 34. BOC Sciences CD38 Monoclonal Antibodies Product and Solutions
Table 35. BOC Sciences CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Creative Biolabs Corporate Information, Location and Competitors
Table 37. Creative Biolabs CD38 Monoclonal Antibodies Major Business
Table 38. Creative Biolabs CD38 Monoclonal Antibodies Total Revenue (USD Million) (2017-2018)
Table 39. Creative Biolabs SWOT Analysis
Table 40. Creative Biolabs CD38 Monoclonal Antibodies Product and Solutions
Table 41. Creative Biolabs CD38 Monoclonal Antibodies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global CD38 Monoclonal Antibodies Revenue (Million USD) by Players (2015-2020)
Table 43. Global CD38 Monoclonal Antibodies Revenue Share by Players (2015-2020)
Table 44. Global CD38 Monoclonal Antibodies Revenue (Million USD) by Regions (2015-2020)
Table 45. Global CD38 Monoclonal Antibodies Revenue Market Share by Regions (2015-2020)
Table 46. North America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
Table 47. North America CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 48. Europe CD38 Monoclonal Antibodies Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific CD38 Monoclonal Antibodies Revenue (Million USD) by Countries (2015-2020)
Table 50. South America CD38 Monoclonal Antibodies Revenue by Countries (2015-2020)
Table 51. South America CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa CD38 Monoclonal Antibodies Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Table 54. Global CD38 Monoclonal Antibodies Revenue (Million USD) by Type (2015-2020)
Table 55. Global CD38 Monoclonal Antibodies Revenue Share by Type (2015-2020)
Table 56. Global CD38 Monoclonal Antibodies Revenue Forecast by Type (2021-2025)
Table 57. Global CD38 Monoclonal Antibodies Revenue by Application (2015-2020)
Table 58. Global CD38 Monoclonal Antibodies Revenue Share by Application (2015-2020)
Table 59. Global CD38 Monoclonal Antibodies Revenue Forecast by Application (2021-2025)
Table 60. Global CD38 Monoclonal Antibodies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. CD38 Monoclonal Antibodies Picture
Figure 2. Global CD38 Monoclonal Antibodies Revenue Market Share by Type in 2019
Figure 3. Daratumumab Picture
Figure 4. Isatuximab Picture
Figure 5. CD38 Monoclonal Antibodies Revenue Market Share by Application in 2019
Figure 6. Pharmacy Picture
Figure 7. Laboratory Use Picture
Figure 8. Global CD38 Monoclonal Antibodies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global CD38 Monoclonal Antibodies Revenue Share by Players in 2019
Figure 16. Global Top 5 Players CD38 Monoclonal Antibodies Revenue Market Share in 2019
Figure 17. Global Top 10 Players CD38 Monoclonal Antibodies Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global CD38 Monoclonal Antibodies Revenue Market Share by Regions (2015-2020)
Figure 21. Global CD38 Monoclonal Antibodies Revenue Market Share by Regions in 2018
Figure 22. North America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 23. Europe CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 25. South America CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 27. North America CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 28. North America CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 29. USA CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 30. Canada CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 31. Mexico CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 32. Europe CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 33. Europe CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 34. Germany CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 35. UK CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 36. France CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 37. Russia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 38. Italy CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 41. China CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 42. Japan CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 43. Korea CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 44. India CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 46. South America CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 47. South America CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 48. Brazil CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 49. Argentina CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 53. UAE CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 54. Egypt CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 55. South Africa CD38 Monoclonal Antibodies Revenue and Growth Rate (2015-2020)
Figure 56. Global CD38 Monoclonal Antibodies Revenue Share by Type (2015-2020)
Figure 57. Global CD38 Monoclonal Antibodies Revenue Share by Type in 2019
Figure 58. Global CD38 Monoclonal Antibodies Market Share Forecast by Type (2021-2025)
Figure 59. Global Daratumumab Revenue Growth Rate (2015-2020)
Figure 60. Global Isatuximab Revenue Growth Rate (2015-2020)
Figure 61. Global CD38 Monoclonal Antibodies Revenue Share by Application (2015-2020)
Figure 62. Global CD38 Monoclonal Antibodies Revenue Share by Application in 2019
Figure 63. Global CD38 Monoclonal Antibodies Market Share Forecast by Application (2021-2025)
Figure 64. Global Pharmacy Revenue Growth Rate (2015-2020)
Figure 65. Global Laboratory Use Revenue Growth Rate (2015-2020)
Figure 66. Global CD38 Monoclonal Antibodies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global CD38 Monoclonal Antibodies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global CD38 Monoclonal Antibodies Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
Figure 70. Europe CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
Figure 72. South America CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa CD38 Monoclonal Antibodies Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---